临床内科杂志
臨床內科雜誌
림상내과잡지
JOURNAL OF CLINICAL INTERNAL MEDICINE
2015年
7期
462-464
,共3页
高通量血液透析%维持性血液透析%皮肤瘙痒%生活质量
高通量血液透析%維持性血液透析%皮膚瘙癢%生活質量
고통량혈액투석%유지성혈액투석%피부소양%생활질량
High-flux hemodialysis%Maintenance hemodialysis%Pruritus%Quality of life
目的:探讨高通量血液透析(HFHD)对改善维持性血液透析(MHD)患者皮肤瘙痒及生活质量的疗效分析。方法44例 MHD 皮肤瘙痒患者随机分为 HFHD 治疗组22例和低通量血液透析治疗组(LFHD 组)22例,共治疗24周,比较两组患者治疗前后皮肤瘙痒缓解率、生活质量评分(SF-36量表)及血清钙、磷、肌酐、β2微球蛋白(β2-MG)、甲状旁腺激素(PTH)、超敏 C 反应蛋白(hs-CRP)的影响。结果治疗24周后 HFHD 治疗组皮肤瘙痒总缓解率为63.6%(14/22),明显高于 LFHD 组(27.3%,6/22),两组比较差异有统计学意义(P <0.01);治疗24周后 HFHD 治疗组 SF-36量表评分为(394.2±28.4)分,LFHD 组 SF-36量表评分为(322.3±26.8)分,两组比较差异有统计学意义(P <0.01);治疗24周后 HFHD 治疗组血清 PTH、β2-MG、hs-CRP 水平明显低于LFHD 组(P <0.05),而血磷、血钙、血肌酐两组比较差异无统计学意义(P >0.05)。结论HFHD可以有效清除 MHD 患者血清中 PTH、β2-MG、hs-CRP 等中大分子毒素及炎症因子,是临床改善MHD 患者皮肤瘙痒的一种有效的方法,并可提高患者的生活质量。
目的:探討高通量血液透析(HFHD)對改善維持性血液透析(MHD)患者皮膚瘙癢及生活質量的療效分析。方法44例 MHD 皮膚瘙癢患者隨機分為 HFHD 治療組22例和低通量血液透析治療組(LFHD 組)22例,共治療24週,比較兩組患者治療前後皮膚瘙癢緩解率、生活質量評分(SF-36量錶)及血清鈣、燐、肌酐、β2微毬蛋白(β2-MG)、甲狀徬腺激素(PTH)、超敏 C 反應蛋白(hs-CRP)的影響。結果治療24週後 HFHD 治療組皮膚瘙癢總緩解率為63.6%(14/22),明顯高于 LFHD 組(27.3%,6/22),兩組比較差異有統計學意義(P <0.01);治療24週後 HFHD 治療組 SF-36量錶評分為(394.2±28.4)分,LFHD 組 SF-36量錶評分為(322.3±26.8)分,兩組比較差異有統計學意義(P <0.01);治療24週後 HFHD 治療組血清 PTH、β2-MG、hs-CRP 水平明顯低于LFHD 組(P <0.05),而血燐、血鈣、血肌酐兩組比較差異無統計學意義(P >0.05)。結論HFHD可以有效清除 MHD 患者血清中 PTH、β2-MG、hs-CRP 等中大分子毒素及炎癥因子,是臨床改善MHD 患者皮膚瘙癢的一種有效的方法,併可提高患者的生活質量。
목적:탐토고통량혈액투석(HFHD)대개선유지성혈액투석(MHD)환자피부소양급생활질량적료효분석。방법44례 MHD 피부소양환자수궤분위 HFHD 치료조22례화저통량혈액투석치료조(LFHD 조)22례,공치료24주,비교량조환자치료전후피부소양완해솔、생활질량평분(SF-36량표)급혈청개、린、기항、β2미구단백(β2-MG)、갑상방선격소(PTH)、초민 C 반응단백(hs-CRP)적영향。결과치료24주후 HFHD 치료조피부소양총완해솔위63.6%(14/22),명현고우 LFHD 조(27.3%,6/22),량조비교차이유통계학의의(P <0.01);치료24주후 HFHD 치료조 SF-36량표평분위(394.2±28.4)분,LFHD 조 SF-36량표평분위(322.3±26.8)분,량조비교차이유통계학의의(P <0.01);치료24주후 HFHD 치료조혈청 PTH、β2-MG、hs-CRP 수평명현저우LFHD 조(P <0.05),이혈린、혈개、혈기항량조비교차이무통계학의의(P >0.05)。결론HFHD가이유효청제 MHD 환자혈청중 PTH、β2-MG、hs-CRP 등중대분자독소급염증인자,시림상개선MHD 환자피부소양적일충유효적방법,병가제고환자적생활질량。
Objective To investigate the clinical efficacy of high-flux hemodialysis(HFHD)for treating pruritus in the maintenance hemodialysis (MHD)patients.Methods 42 MHD patients with pruritus were randomly divided into HFHD treatment group(22 cases)and low-flux hemodialysis(LFHD) treatment group(20 cases)which were treated for 24 weeks,prospectively observed the remission rate of pruritus,quality of life (SF-36 scale ),calcium,phosphorus,creatinine,serum beta 2-microglobulin (β2-MG),parathyroid hormone (PTH),hypersensitive C-reactive protein (hs-CRP) in two groups. Results The total remission rate of pruritus was 63.6% in HFHD group significantly higher than the LFHD group(27.3%)after 24 weeks treatment(P <0.01);The SF-36 scale in HFHD group were 394.2 ±28.4, significantly higher than the LFHD group(322.3 ±26.8)after 24 weeks treatment(P <0.01).The serum levels of β2-MG,PTH,hs-CRP in HFHD group significantly lower than the LFHD group after 24 weeks treatment(P <0.05 ),but there were no significant differences with the serum levels of phosphorus, calcium,serum creatinine in two groups(P >0.05).Conclusion The HFHD could remove the middle to macromolecule toxins of PTH,β2-MG and inflammatory cytokines of hs-CRP which was an effective method for treating pruritus and improved the quality of life in MHD patients with pruritus.